A comprehensive clinical trajectory of EGFR A763_Y764insFQEA-positive non-small cell lung cancer treated with fifth-line osimertinib following circulating tumor DNA-based detection: a case report

Tomohiro Oba, Kenji Kusano, Hidekazu Matsushima